Oct 13, 2020ICR to study fadraciclib to treat paediatric neuroblastomaThe Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma. Read more: https://www.clinicaltrialsarena.com/news/icr-fadraciclib-neuroblastoma/
The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma. Read more: https://www.clinicaltrialsarena.com/news/icr-fadraciclib-neuroblastoma/
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies